Prostate Cancer
Prostate cancer is a type of cancer that occurs in the prostate, a small gland that produces seminal fluid in men. It can lead to symptoms such as difficulty urinating, blood in urine, and pelvic discomfort.
Prostate Cancer: Personalized Radiotherapy and Hormone Therapy
We are studying whether using AI to customize radiotherapy and hormone treatment can help prostate cancer patients while reducing the overall treatment time. This trial is for those with high-risk localized prostate cancer.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have prostate cancer confirmed by a biopsy?
- Have you had any prior surgery on your prostate, like a radical prostatectomy?
- Have you had any radiation treatment to your prostate or pelvis?
- Do you have any serious health issues that would make treatment unsafe, like severe heart or lung problems?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Algonad
Golexin
Golexin La
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Linac-Pet Scan Opco Limited
Radiation therapy
Limassol, Cyprus
Sponsor: Linac-Pet Scan Opco Limited
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.